Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection
Published: 24 November 2021| Version 2 | DOI: 10.17632/4bmkxb4r2x.2
Contributor:
Arjun PuranikDescription
These are the scripts (+ supplement) used in the analysis for the paper "Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection" Puranik, Lenehan et al. *v2: added the paper supplement
Files
Institutions
Mayo Clinic Research
Categories
Epidemiology, COVID-19